跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACT GEMCITABINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACT GEMCITABINE
Authorized
STANDARD
ACT GEMCITABINE
actavis pharma company
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d7f04775fe730651
Company
actavis pharma company
Type
Standard
Approval Details
Approval Id
d7f04775fe730651
Drug Approval Canada Name
ACT GEMCITABINE
Product Name
ACT GEMCITABINE
Status
Cancelled Post Market
Status Date
2019-08-13
Original Market Date
2016-05-02
Din
02433117
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC05 GEMCITABINE
Atc Name
l 01 bc 05
Aig Number
0133122005
Company Name
actavis pharma company
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
GEMCITABINE (GEMCITABINE HYDROCHLORIDE)
38 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d7f04775fe730651
Type
Standard
Back to Health Canada Approvals